BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhang CJ, Zhang JY, Li LJ, Xu NW. Refractory lymphoma treated with chimeric antigen receptor T cells combined with programmed cell death-1 inhibitor: A case report. World J Clin Cases 2022; 10(21): 7502-7508 [PMID: 36157987 DOI: 10.12998/wjcc.v10.i21.7502]
URL: https://www.wjgnet.com/2307-8960/full/v10/i21/7502.htm
Number Citing Articles
1
AntineoplasticsReactions Weekly 2022; 1931(1): 76 doi: 10.1007/s40278-022-26873-7